More articles from Radiopharmaceutical Therapy II

You have access
Sensitized ⁶⁴Cu-ATSM internal radiotherapy targeting tumor malignant regions: approach based on its biological characteristics
Yukie Yoshii, Takako Furukawa, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Yasushi Kiyono, Ming-Rong Zhang, Yasuhisa Fujibayashi and Tsuneo Saga

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 340;
You have access
[¹⁷⁷]Lu-pentixather: preclinical and first patient results with a highly promising CXCR4-directed endoradiotherapeutic agent
Margret Schottelius, Theresa Osl, Andreas Poschenrieder, Ken Herrmann, Constantin Lapa, F. Hoffmann, Markus Schwaiger, Michael Lassmann, Andreas Buck and Hans Wester

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 339;
You have access
Wider safety window with radiolabeled somatostatin receptor antagonists over agonists.
Guillaume Nicolas, Rosalba Mansi, Sandra Vomstein, Jens Kaufmann, Hakim Bouterfa, Helmut Maecke, Damian Wild and Melpomeni Fani

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 335;
You have access
L-Lysine As Kidney Protectant In Targeted Alpha Therapy With ²¹³Bi-DOTATATE
Ho Sze Chan, Mark Konijnenberg, Tamara Anderson, Monique Nysus, Erik de Blois, Robert Atcher, Wouter Breeman, Marion de Jong and Jeffrey Norenberg

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 338;
You have access
Quantitative biodistribution & kinetics of a new formulation of [Lu-177]-Octreotate
Dale Bailey, Thomas Hennessy, Kathy Willowson, Geoffrey Schembri, Paul Roach, Graeme Snowdon, Alireza Aslani, Nick Pavlakis and Stephen Clarke

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 336;
You have access
Feasibility of a combination of ⁹⁰Y/¹⁷⁷Lu-Radiopeptide Therapy (PRRT) and External Beam Radiation Therapy (RT) in neuroendocrine tumors (NETs): preliminary report on 25 cases
Marta Cremonesi, Cristina Garibaldi, Mahila Ferrari, Lisa Bodei, Dario Zerini, Francesca Botta, Federica Cattani, Barbara Jereczek, Chiara Grana and Roberto Orecchia

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 337;
You have access
Combined treatment planning and therapy using ¹⁵³Sm-EDTMP RPT with XRT in pediatric metastatic osteosarcoma patients
Anders Josefsson, Robert Hobbs, Thibault Mauxion, Eric Frey, Stephanie Terezakis, Christian Meyer, David Loeb and George Sgouros

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 341;
You have access
Early outcome of I-131 ablation in differentiated thyroid cancer: 100mCi versus 150mCi
Ye Young Seo, Joo Hyun O, Sae Jung Na, Sung Hoon Kim and Young Ha Park

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 155;
You have access
Influence of endoscopic total thyroidectomy on postoperative thyroid remnant
Hyung Jun Im, Il han Lim, Jin Chul Paeng, Do Hoon Koo, Kyu Eun Lee, Yeo-Kyu Youn, June Chung and Dong Soo Lee

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 156;
You have access
Survival and response after selective internal radiation therapy (SIRT) for advanced hepatocellular carcinoma with and without portal vein thrombosis
Monia Hamami, Gerald Antoch, Stefan Mueller, Judith Ertle, Christian Boy, Thorsten Poeppel, Philip Hilgard and Andreas Bockisch

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 160;

Main menu

User menu

Search

More articles from Radiopharmaceutical Therapy II

Pages